[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339085-105":59,"doc-detail-339085-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prom2-overexpression-induces-metastatic-potential-through-epithelial-to-mesenchymal-transition-and-ferroptosis-resistance-in-human-cancers","PROM2 overexpression induces metastatic potential through epithelial-to-mesenchymal transition and ferroptosis resistance in human cancers","","Despite therapeutic progress over the past two decades, metastatic cancers continue to drive mortality. This translational research investigates how PROM2 regulates the metastatic program and resistance to cell death, with emphasis on metastatic melanoma. The study demonstrates PROM2 overexpression enhances metastatic potential via increased EMT marker expression and ferroptosis resistance, observed in melanoma and additional cancer models. Antisense inhibition of PROM2 reduces its expression and prevents metastases in melanoma xenografts, and reveals an aggravation loop linking cancer hallmarks.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prom2-overexpression-induces-metastatic-potential-through-epithelial-to-mesenchymal-transition-and-ferroptosis-resistance-in-human-cancers/339085/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prom2-overexpression-induces-metastatic-potential-through-epithelial-to-mesenchymal-transition-and-ferroptosis-resistance-in-human-cancers/339085.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is PROM2 in the context of metastatic disease?","Question",{"text":112,"@type":113},"PROM2 is investigated as a biomarker and bio-target connected to distant metastases and reduced survival, and it supports cancer hallmarks relevant to metastasis and cell death resistance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does PROM2 overexpression affect cancer progression?",{"text":117,"@type":113},"PROM2 overexpression is linked to increased metastatic potential through elevated epithelial-to-mesenchymal transition (EMT) marker expression and ferroptosis resistance.",{"name":119,"@type":110,"acceptedAnswer":120},"Can PROM2 inhibition reduce metastasis in melanoma models?",{"text":121,"@type":113},"Yes. Using an oligonucleotide antisense approach to decrease PROM2 expression, metastases were prevented in melanoma xenograft models.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339085,1790193043,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","DOI: 10.1002/ctm2.1632  \nRESEARCH ARTICLE  \nPROM2 overexpression induces metastatic potential through epithelial-to-mesenchymal transition and ferroptosis resistance in human cancers  \nJustine Paris1   Claire Wilhelm2  Celeste Lebbé3, 4  Mohammed Elmallah5 Frédéric Pamoukdjian1, 6, 7  Audrey Héraud5  Guillaume Gapihan1   \nAurore Van De Walle2   Van Nhan Tran8  Diaddin Hamdan1, 9   \nClara Allayous3, 4  Maxime Battistella3, 10  Emmanuel Van Glabeke11 Kah Wai Lim8  Christophe Leboeuf1  Sébastien Roger5  Géraldine Falgarone1, 6, 12  Anh Tuan Phan7, 13  Guilhem Bousquet1, 6, 14  \n1Université Paris Cité, INSERM, UMR_S942 MASCOT, Paris, France  \n2 Laboratoire Physico Chimie Curie, Institut Curie, CNRS, PSL Research University, Paris, France  \n3Université Paris Cité, INSERM, Paris, France  \n4APHP, Dermatolo-Oncology, Hôpital Saint Louis, Paris, France  \n5 Inserm U1327 ISCHEMIA, Université de Tours, Faculté de Médecine, Tours, France  \n6APHP, Hôpital Avicenne, Médecine Gériatrique, Bobigny, France  \n7Université Sorbonne Paris Nord, Villetaneuse, France  \n8 School of Physical and Mathematical Sciences, Nanyang Technological University, Singapore, Singapore  \n9 Hôpital La Porte Verte, Cancérologie, Versailles, France  \n10 Pathology Department, APHP, Hôpital Saint Louis, Paris, France  \n11 Fédération d’Urologie de  \nSeine-Saint-Denis, CHI Robert Ballangé, Aulnay-sous-Bois, France  \n12APHP, Hôpital Avicenne, Unité de Médecine Ambulatoire (UMA), Bobigny, France  \n13NTU Institute of Structural Biology, Nanyang Technological University, Singapore, Singapore  \nGraphical Abstract  \n1. In human metastatic melanoma, PROM2 is the cornerstone of two cancer hallmarks: the metastatic process and resistance to ferroptotic cell death.  \n2. The invasive and migration phenotypes linked to PROM2 overexpression are associated with an EMT phenotype.  \nClin. Transl. Med. 2024;14:e1632 .  \n[https://doi.org/10.1002/ctm2.1632](https://doi.org/10.1002/ctm2.1632)  \n[wileyonlinelibrary.com/journal/ctm2](wileyonlinelibrary.com/journal/ctm2)  \nPARIS et al.  \n14APHP, Hôpital Avicenne, Oncologiemédical, Bobigny, France  \nCorrespondence  \nGuilhemBousquet, INSERMU942, Université Sorbonne Paris Nord, SMBH, Rue deChablis, Bobigny 93000, France. [Email:](Email: guilhem.bousquet@aphp.fr)[ guilhem.bousquet@aphp.fr](Email: guilhem.bousquet@aphp.fr)  \n3. The combination of these two cancer hallmarks, by way on an aggravation loop, contributes to increasing the metastatic burden, leading to death.  \nDOI: 10.1002/ctm2.1632  \nRESEARCH ARTICLE  \nPROM2 overexpression induces metastatic potential through epithelial-to-mesenchymal transition and ferroptosis resistance in human cancers  \nJustine Paris1   Claire Wilhelm2  Celeste Lebbé3, 4  Mohammed Elmallah5 Frédéric Pamoukdjian1, 6, 7  Audrey Héraud5  Guillaume Gapihan1   \nAurore Van De Walle2   Van Nhan Tran8  Diaddin Hamdan1, 9   \nClara Allayous3, 4  Maxime Battistella3, 10  Emmanuel Van Glabeke11 Kah Wai Lim8  Christophe Leboeuf1  Sébastien Roger5  Géraldine Falgarone1, 6, 12  Anh Tuan Phan7, 13  Guilhem Bousquet1, 6, 14  \n1Université Paris Cité, INSERM, UMR_S942 MASCOT, Paris, France  \n2 Laboratoire Physico Chimie Curie, Institut Curie, CNRS, PSL Research University, Paris, France  \n3Université Paris Cité, INSERM, Paris, France  \n4APHP, Dermatolo-Oncology, Hôpital Saint Louis, Paris, France  \n5 Inserm U1327 ISCHEMIA, Université de Tours, Faculté de Médecine, Tours, France  \n6APHP, Hôpital Avicenne, Médecine Gériatrique, Bobigny, France  \n7Université Sorbonne Paris Nord, Villetaneuse, France  \n8 School of Physical and Mathematical Sciences, Nanyang Technological University, Singapore, Singapore  \n9 Hôpital La Porte Verte, Cancérologie, Versailles, France  \n10 Pathology Department, APHP, Hôpital Saint Louis, Paris, France  \n11 Fédération d’Urologie de Seine-Saint-Denis, CHI Robert Ballangé, Aulnay-sous-Bois, France  \n12APHP, Hôpital Avicenne, Unité de Médecine Ambulatoire (UMA), Bobigny, France  \n13NTU Institute of Structural Biolo","cbCaioc0aZbur8Vo","https://ap.wps.com/l/cbCaioc0aZbur8Vo","pdf",6651397,24,"English","# Abstract\n## Introduction\n## Methods and results\n## Conclusions","[{\"question\":\"What is PROM2 in the context of metastatic disease?\",\"answer\":\"PROM2 is investigated as a biomarker and bio-target connected to distant metastases and reduced survival, and it supports cancer hallmarks relevant to metastasis and cell death resistance.\"},{\"question\":\"How does PROM2 overexpression affect cancer progression?\",\"answer\":\"PROM2 overexpression is linked to increased metastatic potential through elevated epithelial-to-mesenchymal transition (EMT) marker expression and ferroptosis resistance.\"},{\"question\":\"Can PROM2 inhibition reduce metastasis in melanoma models?\",\"answer\":\"Yes. Using an oligonucleotide antisense approach to decrease PROM2 expression, metastases were prevented in melanoma xenograft models.\"}]","PROM2 overexpression induces metastatic potential through epithelial-to-mesenchymal transition and ferroptosis resistance in human cancers | PDF",1790027766,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/90f560466ae2c088b20f8d8525c4b5ba.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db7befa753bee2c1b34599aeea8021d6.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/04121d00bd1059dee858b96179a53dc7.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/465de0e267fbcdcb162ac0f2a745e2a9.webp",980,1287]